Capricor Investors Can Lead Securities Fraud Lawsuit
Purchasers of Capricor Therapeutics, Inc. securities may have the opportunity to serve as lead plaintiff in a securities fraud lawsuit. The deadline to file is September 28, 2026.
Rosen Law Firm has notified purchasers of Capricor Therapeutics, Inc. (NASDAQ: CAPR) securities who acquired them between December 17, 2025, and July 26, 2026, inclusive, of the opportunity to seek the role of lead plaintiff in a class action lawsuit. The suit alleges violations of federal securities laws.
The law firm has set a deadline of September 28, 2026, for investors to file a lead plaintiff motion. This deadline is critical for potential class members seeking to participate in the litigation.
Rosen Law Firm is experienced in prosecuting securities class actions. The firm encourages investors who believe they may have sustained losses to contact them for further information regarding their rights and the ongoing litigation.